Tenax Therapeutics, Inc. · NASDAQ:TENX
Perceptive Advisors LLC reported a 5.50% stake in Tenax Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Perceptive Advisors LLC reported a 5.50% stake in Tenax Therapeutics, Inc., 1,447,782 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 5.50%
- Shares
- 1,447,782
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 5.50% | 1,447,782 |
| Joseph Edelman | 5.50% | 1,447,782 |
| Perceptive Life Sciences Master Fund, Ltd. | 5.50% | 1,447,782 |
Source
Related
- Tenax Therapeutics, Inc.
- Perceptive Advisors LLC
- Tenax Therapeutics, Inc. shareholders
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Feb 17, 2026
- Schedule 13G · Perceptive Advisors LLC · Dec 23, 2025
- Form 4 · ADAR1 Capital Management, LLC · Oct 21, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 15, 2026
- Schedule 13G/A · Sphera Funds Management LTD. · Oct 13, 2026
- Schedule 13G/A · Dellora Investments LP · Oct 9, 2026
- Form 4 · Doogan Declan · Sep 17, 2026